Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi
Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on pe...
Gespeichert in:
Veröffentlicht in: | Cancers 2021-07, Vol.13 (14), p.3401 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 14 |
container_start_page | 3401 |
container_title | Cancers |
container_volume | 13 |
creator | Franceschetti, Silvia Annunziata, Maria Antonietta Agostinelli, Giulia Gerardi, Chiara Allocati, Eleonora Minoia, Carla Guarini, Attilio |
description | Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice. |
doi_str_mv | 10.3390/cancers13143401 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555103522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEolXbM1dLXLikdfyVLAekElpaKYDElnM0ccZZl8Re7CRo-Xv8sabbio_6YmveZ16NX02SvMroKecreqbBaQwx45nggmbPkkNGc5YqtRLP_3kfJCcx3tLlcJ7lKn-ZHHDBVoXK1GHyu4IRyWecgu99ZzX0BFxLSt85O9oZyRp_TNgD7suVd116g2Egn_yi-2BdR7whZQ8x7puvfNt9t45Uu2G78QPs2z5YY6aIpILQIXmfltj3f4n1FGY7-xDfknOy3sURBxitJl9xtviTNDsybpBcetfCL-sdkusRegsOSGWd8YM9Tl4Y6COePN5HybfLi5vyKq2-fLwuz6tU81Uxpko2hWSKAULOGs0NomlBAFUoGs6Nyg1lmZICluhQSNBCaamkEY0qtDT8KHn34LudmgFbjW4M0NfbYAcIu9qDrf9XnN3UnZ_rgtNcUbkYvHk0CH5JNY71YKNewgCHfoo1k1JmlEvGFvT1E_TWT8Et37unhFBcFnShzh4oHXyMAc2fYTJa3-9I_WRH-B3MG7Le</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554463580</pqid></control><display><type>article</type><title>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Franceschetti, Silvia ; Annunziata, Maria Antonietta ; Agostinelli, Giulia ; Gerardi, Chiara ; Allocati, Eleonora ; Minoia, Carla ; Guarini, Attilio</creator><creatorcontrib>Franceschetti, Silvia ; Annunziata, Maria Antonietta ; Agostinelli, Giulia ; Gerardi, Chiara ; Allocati, Eleonora ; Minoia, Carla ; Guarini, Attilio</creatorcontrib><description>Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13143401</identifier><identifier>PMID: 34298616</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Anxiety ; B-cell lymphoma ; Bias ; Cancer therapies ; Cognitive ability ; Disease ; Fatigue ; Hodgkin's lymphoma ; Literature reviews ; Lymphocytes B ; Lymphoma ; Mental depression ; Neurological complications ; Neuropsychology ; Neurotoxicity ; Peripheral neuropathy ; Population ; Population studies ; Quality of life ; Stem cell transplantation ; Systematic Review ; Young adults</subject><ispartof>Cancers, 2021-07, Vol.13 (14), p.3401</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</citedby><cites>FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</cites><orcidid>0000-0002-5707-0689</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307605/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307605/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Franceschetti, Silvia</creatorcontrib><creatorcontrib>Annunziata, Maria Antonietta</creatorcontrib><creatorcontrib>Agostinelli, Giulia</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Allocati, Eleonora</creatorcontrib><creatorcontrib>Minoia, Carla</creatorcontrib><creatorcontrib>Guarini, Attilio</creatorcontrib><title>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</title><title>Cancers</title><description>Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.</description><subject>Anxiety</subject><subject>B-cell lymphoma</subject><subject>Bias</subject><subject>Cancer therapies</subject><subject>Cognitive ability</subject><subject>Disease</subject><subject>Fatigue</subject><subject>Hodgkin's lymphoma</subject><subject>Literature reviews</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Mental depression</subject><subject>Neurological complications</subject><subject>Neuropsychology</subject><subject>Neurotoxicity</subject><subject>Peripheral neuropathy</subject><subject>Population</subject><subject>Population studies</subject><subject>Quality of life</subject><subject>Stem cell transplantation</subject><subject>Systematic Review</subject><subject>Young adults</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkk1v1DAQhiMEolXbM1dLXLikdfyVLAekElpaKYDElnM0ccZZl8Re7CRo-Xv8sabbio_6YmveZ16NX02SvMroKecreqbBaQwx45nggmbPkkNGc5YqtRLP_3kfJCcx3tLlcJ7lKn-ZHHDBVoXK1GHyu4IRyWecgu99ZzX0BFxLSt85O9oZyRp_TNgD7suVd116g2Egn_yi-2BdR7whZQ8x7puvfNt9t45Uu2G78QPs2z5YY6aIpILQIXmfltj3f4n1FGY7-xDfknOy3sURBxitJl9xtviTNDsybpBcetfCL-sdkusRegsOSGWd8YM9Tl4Y6COePN5HybfLi5vyKq2-fLwuz6tU81Uxpko2hWSKAULOGs0NomlBAFUoGs6Nyg1lmZICluhQSNBCaamkEY0qtDT8KHn34LudmgFbjW4M0NfbYAcIu9qDrf9XnN3UnZ_rgtNcUbkYvHk0CH5JNY71YKNewgCHfoo1k1JmlEvGFvT1E_TWT8Et37unhFBcFnShzh4oHXyMAc2fYTJa3-9I_WRH-B3MG7Le</recordid><startdate>20210707</startdate><enddate>20210707</enddate><creator>Franceschetti, Silvia</creator><creator>Annunziata, Maria Antonietta</creator><creator>Agostinelli, Giulia</creator><creator>Gerardi, Chiara</creator><creator>Allocati, Eleonora</creator><creator>Minoia, Carla</creator><creator>Guarini, Attilio</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5707-0689</orcidid></search><sort><creationdate>20210707</creationdate><title>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</title><author>Franceschetti, Silvia ; Annunziata, Maria Antonietta ; Agostinelli, Giulia ; Gerardi, Chiara ; Allocati, Eleonora ; Minoia, Carla ; Guarini, Attilio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anxiety</topic><topic>B-cell lymphoma</topic><topic>Bias</topic><topic>Cancer therapies</topic><topic>Cognitive ability</topic><topic>Disease</topic><topic>Fatigue</topic><topic>Hodgkin's lymphoma</topic><topic>Literature reviews</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Mental depression</topic><topic>Neurological complications</topic><topic>Neuropsychology</topic><topic>Neurotoxicity</topic><topic>Peripheral neuropathy</topic><topic>Population</topic><topic>Population studies</topic><topic>Quality of life</topic><topic>Stem cell transplantation</topic><topic>Systematic Review</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franceschetti, Silvia</creatorcontrib><creatorcontrib>Annunziata, Maria Antonietta</creatorcontrib><creatorcontrib>Agostinelli, Giulia</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Allocati, Eleonora</creatorcontrib><creatorcontrib>Minoia, Carla</creatorcontrib><creatorcontrib>Guarini, Attilio</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franceschetti, Silvia</au><au>Annunziata, Maria Antonietta</au><au>Agostinelli, Giulia</au><au>Gerardi, Chiara</au><au>Allocati, Eleonora</au><au>Minoia, Carla</au><au>Guarini, Attilio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</atitle><jtitle>Cancers</jtitle><date>2021-07-07</date><risdate>2021</risdate><volume>13</volume><issue>14</issue><spage>3401</spage><pages>3401-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34298616</pmid><doi>10.3390/cancers13143401</doi><orcidid>https://orcid.org/0000-0002-5707-0689</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2021-07, Vol.13 (14), p.3401 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307605 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central |
subjects | Anxiety B-cell lymphoma Bias Cancer therapies Cognitive ability Disease Fatigue Hodgkin's lymphoma Literature reviews Lymphocytes B Lymphoma Mental depression Neurological complications Neuropsychology Neurotoxicity Peripheral neuropathy Population Population studies Quality of life Stem cell transplantation Systematic Review Young adults |
title | Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A50%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20Neurological%20and%20Cognitive%20Sequelae%20and%20Long-Term%20Monitoring%20of%20Classical%20Hodgkin%20Lymphoma%20and%20Diffuse%20Large%20B-Cell%20Lymphoma%20Survivors:%20A%20Systematic%20Review%20by%20the%20Fondazione%20Italiana%20Linfomi&rft.jtitle=Cancers&rft.au=Franceschetti,%20Silvia&rft.date=2021-07-07&rft.volume=13&rft.issue=14&rft.spage=3401&rft.pages=3401-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13143401&rft_dat=%3Cproquest_pubme%3E2555103522%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2554463580&rft_id=info:pmid/34298616&rfr_iscdi=true |